依达拉奉联合奥扎格雷钠联合治疗急性进展性脑梗死的疗效观察

目的研究依达拉奉联合奥扎格雷钠治疗120例急性进展性脑梗死的临床疗效。方法 120例急性脑梗死患者,随机将其分为一般对照组60例和治疗组60例。对于一般对照组和联合静脉溶栓亚低温治疗组,均给予常规治疗,复方丹参注射液和奥扎格雷钠静脉滴注和口服肠溶阿司匹林片;对于治疗组,给予依达拉奉联合奥扎格雷钠联合治疗。结果治疗组患者的临床疗效均明显优于对照组,与对照组相比较,具有显著性差异(P<0.05)。治疗组患者神经功能缺损程度评分效果明显优于对照组,与对照组相比较,具有显著性差异(P<0.05)。结论依达拉奉联合奥扎格雷钠联合治疗急性进展性脑梗死患者是安全有效的方法。

Efficacy of in Accordance with Edaravone combined with Ozagrel Sodium for Treatment of Acute Progressing Stroke

Objective To study the treatment of 120 cases of acute progressive cerebral infarction edaravone United Ozagrel sodium. Methods 120 patients with acute cerebral infarction were randomly divided into the general control group of 60 cases and the treatment group 60 cases. For the normal control group and in combination with intravenous thrombolysis mild hypothermia treatment group were given conventional treatment, compound Danshen injection and ozagrel sodium intravenous infusion and oral administration of enteric-coated aspirin tablets; treatment group, giving the the edaravone United Aozha Gray sodium combination therapy. Results The clinical efficacy of the treatment group were significantly better than the control group compared with the control group, with significant differences （P〈0.05）. Rating effect of the treatment of patients with neurologic impairment than the control group compared with the control group, with significant differences （P〈0.05）. Conclusion According to the United ozagrel sodium edaravone treatment of acute progressing stroke patients is safe and effective method.